Ascletis Pharma, Inc. (HK:1672)
:1672
Comparison Results
Ascletis Pharma, Inc.
HK$17.95
HK$19.05B
-9.33
272.41%
2 Buy
1 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.89
HK$10.55B
-77.24
66.12%
2 Buy
0 Hold
0 Sell
Moderate Buy
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.35B
-3.21
-29.19%
―
Shanghai Henlius Biotech, Inc. Class H
HK$83.35
HK$45.30B
34.57
220.58%
6 Buy
0 Hold
0 Sell
Strong Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.15
HK$4.45B
558.59
-12.59%
―
Performance Comparison
HK:1672
Ascletis Pharma, Inc.
17.95
12.18
211.09%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.78
1.61
38.61%
HK:2171
CARsgen Therapeutics Holdings Ltd.
18.24
5.42
42.28%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
4.90
-2.02
-29.19%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
83.35
53.00
174.63%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
7.15
-1.13
-13.65%